FDA Grants Accelerated Approval to Lifileucel For Treatment of Advanced Melanoma
This marks the first and only time that an individualized T cell therapy has been approved by the FDA for a solid tumor cancer.
Source: pharmacytimes.com
Stay updated with breaking news from Samanthar Guild. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This marks the first and only time that an individualized T cell therapy has been approved by the FDA for a solid tumor cancer.
Lifileucel is the first cellular therapy to be approved to treat patients with unresectable or metastatic melanoma.
AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after anti-PD-1 and targeted therapy AMTAGVI deploys patient-specific immune...